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Abstract
Purpose of Review Fibroblasts, the major cell population in all connective tissues, are best known for their role in depositing and
maintaining the extracellular matrix. Recently, numerous specialised functions have been discovered revealing unpredicted fibro-
blast heterogeneity. We will discuss this heterogeneity, from its origins in development to alterations in fibrotic disease conditions.
Recent Findings Advances in lineage tracing and single-cell transcriptional profiling techniques have revealed impressive
diversity amongst fibroblasts in a range of organ systems including the skin, lung, kidney and heart. However, there are major
challenges in assimilating the findings and understanding their functional significance. Certain fibroblast subsets can make
specific contributions to healthy tissue functioning and to fibrotic disease processes; thus, therapeutic manipulation of particular
subsets could be clinically beneficial.
Summary Here we propose that four key variables determine a fibroblast’s phenotype underpinning their enormous heteroge-
neity: tissue status, regional features, microenvironment and cell state. We review these in different organ systems, highlighting
the importance of understanding the divergent fibroblast properties and underlying mechanisms in tissue fibrosis.
Keywords Fibroblast . Cell heterogeneity . Single-cell transcriptomics . Fibrosis . Tissue injury .Myofibroblast
Introduction
Fibroblasts, the main cell population in connective tissues,
have a reputation for their important structural role of extra-
cellular matrix (ECM) deposition and remodelling, but are
also appreciated to make important contributions to numerous
vital biological processes including wound repair, immune
responses and differentiation into other cell types, whilst con-
tributing to fibrotic disease and tumour development. In spite
of their impressive range of functions, a precise definition of a
fibroblast remains elusive, perhaps because of the enormous
heterogeneity within this cell population. Following a brief
introduction to generalised features of fibroblasts, this review
will discuss recent advances in dissecting the diversity of fi-
broblasts in different organ systems (skin, lung, liver, kidney
and heart), aiming to highlight the functional significance of
different subpopulations in tissue repair and fibrosis.
General Fibroblast Features
Before delving into the divergent features of newly described
fibroblast lineages or subpopulations, it is important to con-
sider some of their conventional properties. Fibroblasts are
migratory and highly proliferative during development; then,
in most adult tissues, they quiesce and persist long term in
homeostasis. These fibroblasts may appear in a passive state,
however, they are highly metabolically active. They continu-
ously deposit and remodel their surrounding ECM, and patrol
the composition and mechanical properties of their environ-
ment. Also, an ability to modulate the immune response by
expressing different cytokines is a common feature.
Upon tissue damage, fibroblasts can quickly exit their qui-
escent state and become “activated” in response to a plethora
of cues. Depending on the cues, cells may start to proliferate,
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migrate to the injury site, differentiate into highly contractile
myofibroblasts and/or increase ECM deposition and remodel-
ling. Ageing and/or environmental stressors (e.g. DNA dam-
age, oxidative stress) can also influence fibroblast biology,
potentially promoting senescence [1].
Fibroblasts are notoriously plastic, as demonstrated by the fact
that they are routinely reprogrammed into inducible pluripotent
stem cells [2]. Differentiation into contractile myofibroblasts is
one in situ example of their cellular plasticity [3], but they also
have the ability to specialise in different tissues, becoming adipo-
cytes and dermal papilla cells or even cartilage-like cells [4] in the
skin, or smooth muscle cells in the lung airway compartment [5].
Interestingly, there are also numerous scenarios in which fibro-
blasts lack plasticity. For example, fibroblasts derived from dis-
eased tissue, such as chronic wounds, fibrosis or cancer, have a
persistent pathological phenotype [6, 7], which likely has an epi-
genetic basis [8]. Similarly, transplantation experiments of gingival
fibroblasts into dorsal skin indicate that they retain aspects of their
original identity, including a relatively non-fibrotic phenotype [9].
Close histological examination of most tissue types shows
a non-uniform stromal compartment (e.g. with variable cell
and matrix density and composition) and indeed the morphol-
ogy and behaviour of the fibroblasts isolated from different
regions within a tissue are also variable [10–15]. Advances in
lineage tracing and transcriptional profiling techniques are
enabling us to better understand the diversity of these fasci-
nating cells, although there are challenges in assimilating the
increasingly abundant data and making sense of it all.
A Strategy for Fibroblast Stratification
We propose that the transcriptomic signature and in turn the
phenotype of any one fibroblast is the product of four layers of
influence (Fig. 1a). First, is the tissue condition/state, which
describes if the tissue is developing, homeostatic, ageing,
regenerating, stressed or diseased. This is followed by a re-
gional or anatomical heterogeneity, which can vary in terms
of tissue composition (e.g. vascularisation, innervation, abun-
dance of fat/muscle), developmental origin (e.g. mesoderm/
neural crest in the skin, epicardium/endothelium in the heart),
microbiome and the requirement for tissue-specific functions
(e.g. supporting hair follicle formation in the skin or bone
resorbtion in the synovium). The third layer is the local
heterogeneity, which reflects the immediate microenviron-
ment of the fibroblast, including the ECM, cell and matrix
interactions, paracrine and autocrine signals and biomechani-
cal cues (e.g. tissue stiffness, shear force). Lastly, the cell
phenotype reflects its state, such as quiescence, proliferation,
senescence, activation, migration or differentiation.
Considering all of these variables, it is perhaps not surprising
that single-cell RNA sequencing (RNA-seq) datasets have re-
vealed extraordinary heterogeneity amongst fibroblast
populations in all tissue types and organ systems. The chal-
lenge now is to consider how these transcriptionally defined
clusters differ with respect to functionality, likely making spe-
cific contributions to healthy tissue homeostasis and disease
processes (Fig. 1b). How this appears in different organ sys-
tems will now be considered.
Fibroblast Heterogeneity in Development,
Homeostasis and Fibrosis
Skin The skin dermis develops from multipotent fibroblasts,
which clonal lineage tracing experiments have revealed are
highly proliferative during embryonic development, but after
birth, they switch to a quiescent state efficient at ECM depo-
sition [16]. The cells then differentiate into spatially distinct
lineages, creating the dermal sublayers: papillary, reticular and
dermal white adipose tissue (DWAT) [17]. Combining com-
putational modelling with lineage tracing suggests that the
organisation of different lineages is controlled by a balance
of cell proliferation and ECM deposition [18•]. Lineage trac-
ing and transcriptomic analyses of mouse skin in homeostasis
have provided insight into the functional variations between
cells in the different layers at single anatomical sites [9, 16, 19,
20, 21•]. Briefly, papillary fibroblasts, beneath the basement
membrane, have an active Wnt signalling signature and are
required for hair follicle formation, giving rise to arrector pili
muscle, dermal papilla and dermal sheath cells. Fibroblasts in
the reticular dermal layer highly express genes associated with
ECM and immune signalling and give rise to lipid-filled adi-
pocytes of the DWAT.
A comparable local diversity is apparent in human skin at
rest; one single-cell RNA-seq analysis identified two major
fibroblast lineages (characterised by co-expression of SFRP2
and DPP4 or FMO1 and LSP1), which could be further
subdivided into several additional subpopulations [22•]. A
similar study distinguished five mesenchymal populations,
which were described as upper and lower dermal fibroblasts,
pericytes and two uncharacterised populations [23•].
Comparing young and old human skin in an extensive
RNA-seq analysis Solé-Boldo et al., identified four major der-
mal fibroblast populations with functionally distinct
transcriptomic signatures and spatial distribution and defined
these as secretory-reticular, secretory-papillary, pro-inflam-
matory and mesenchymal fibroblasts [24]. Notably, another
RNA-seq study mapping six distinct fibroblast populations in
human skin failed to correlate established human papillary and
reticular fibroblast markers to any specific clusters [25]. This
perhaps indicates that the fibroblast transcriptome is strongly
influenced by other factors, such as tissue state and biopsy
location (Fig. 1a).
The importance of tissue state was clearly demonstrated by
a single cell RNA-seq study of mouse skin during hair growth
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uncovering a transient switch in the transcriptional signature
in two of the four identified dermal fibroblast population upon
hair growth induction [21•]. The variations in skin from dif-
ferent anatomical sites include dermal thickness, abundance of
fat, vascularity, nerve density, hair follicle density, and im-
mune cell composition. The dermis also has distinct develop-
mental origins, depending on the site, with the craniofacial
skin uniquely developing from the neural crest cells, whereas
the majority of the body arises from the mesoderm
(reviewed in [26]). All of these variable regional fea-
tures are anticipated to influence the local, functional
heterogeneity being uncovered.
The distinct functionality of the different skin fibroblast
lineages really surface when considered during wound repair
(Fig. 1b). When wounded, all fibroblasts in the surrounding
dermis are exposed to numerous stimuli triggering their “ac-
tivation”, such as serum and significant mechanical changes
[27]. However, fibroblast subpopulations differ in their wound
healing response. For example, lineage-tracing studies in
mouse skin wounds demonstrated that cells in the lower der-
mis are the first to repopulate the damaged tissue and mediate
the ECM deposition, whereas papillary fibroblasts move in
later and may have a role in remodelling and/or appendage
regeneration [18•, 19]. Adipocytes and fascial fibroblasts are
also thought to significantly contribute to wound repair [28,
29], but likely not dermal papilla or arrector pili muscle cells
[30]. Additionally, a perivascular myofibroblast progenitor
with pericyte characteristics and high expression of
ADAM12 (a disintegrin and metalloprotease 12) has been
identified as an important mediator of scarring [31]; however,
to what extent pericytes directly contribute to tissue repair
beyond angiogenesis is still controversial. The heterogeneity
of scar-forming cells within mouse skin wounds has been
further dissected by Guerrero-Juarez et al.; their RNA-seq
analysis identified 12 activated fibroblast clusters, including
a rare myeloid-derived cell population [32•]. These clusters
not only differed in transcription factor and receptor-ligand
expression but also in signatures of signalling pathway acti-
vation, their cell cycle state and spatial distribution. Consistent
with these signatures, it has been discovered that only selec-
tive cell populations respond to certain paracrine signals; for
example, a specific macrophage subset specifically promotes
the proliferation of an activated adipocyte precursor popula-
tion [33•]. Although the functional significance of this cellular
diversity in a wound bed requires further study, it supports the
idea that there are multiple activated fibroblast states.
The influence of tissue age on skin fibroblast heterogeneity
and phenotype has also been addressed; transcriptional profiling
and flow cytometry have revealed that age influences, and indeed
decreases, heterogeneity in homeostasis and wound repair [16,
24, 33•, 34]. This may be attributable to changes in the local
microenvironment (ECM, cellular and paracrine signals), cell
intrinsic factors and systemic metabolism. Heterogeneity may
equally be reduced in skin fibrosis, with specific subpopulations
committed to a particular state of activation or differentiation
dominating the ongoing tissue repair process. In an irradiation-
Fig. 1 Strategies for fibroblast stratification. a Layers of the fibroblast
phenotype. Within a tissue, the diversity of the fibroblast population (e.g. as
identified by single-cell RNA-seq) will be the combined reflection of the
tissue state, regional/anatomical variations, local heterogeneity
(microenvironment) and cellular state. b Discovering how different tissue
states influence fibroblast heterogeneity. Single-cell RNA-seq generally
starts with adult homeostatic tissue to define fibroblast heterogeneity at a
local level (e.g. tissue biopsy; highlighted in grey). These efforts have
revealed subpopulations with distinct functionality that are predominately in
a quiescent state. How these lineages develop is variable between organ
systems, but involves significant proliferation of a pool of multipotent
progenitors that ultimately differentiate into specialised subsets. Upon tissue
injury, fibroblasts become activated and may transiently change their relative
abundances and functionality. New subpopulations (e.g. myofibroblast) may
appear during this process from one or several precursors. More significant
and persistent changes in fibroblast heterogeneity have been observed in
fibrotic disease conditions (e.g. accumulation and dominance of
continuously active myofibroblasts, which themselves are diverse). With
age, fibroblast abundance and diversity decline, which may impair organ
function or ability to regenerate. Cell size indicates fibroblast subpopulation
abundance and the colouring illustrates different cellular states within a
functionally distinct population. schematic provides some illustrative
examples only that is based upon current literature but do not represent a
specific organ system.
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induced skin fibrosis model, a CD26-positive fibroblast subset
developmentally derived from an Engrailed-positive cell popu-
lation is mainly responsible for the fibrotic ECM deposition, and
depletion using a diphtheria toxin strategy improved the pheno-
type [9]. A similar result was achieved by selectively deleting
perivascular pro-fibrotic ADAM12+ progenitors [31]. Thus,
targeting specific fibroblast subpopulations has the promise to
suppress fibrosis development without affecting regenerative fi-
broblast populations.
At the conclusion of a healthy repair process, although there is
inevitably a residual scar, there is in fact the potential for signif-
icant resolution of the scar myofibroblasts. How their fate is
determined and regulated remains largely unclear, but apoptosis
and senescence are common outcomes. We do not yet know
whether different fibroblast populations have varying propensi-
ties to apoptose or senesce, or even if they maintain distinct
properties in the senescent state; certainly, some have relevant
pro-fibrotic properties [35•]. Further differentiation events are
also possible; for example, myofibroblasts stimulated by BMP
signalling from regenerating hair follicles can convert to adipo-
cytes and replenish the DWAT [36], and myofibroblasts influ-
enced by epidermal hedgehog signalling can adopt a dermal
papilla fate, which in turn is able to stimulate hair follicle
neogenesis [37]. It will be interesting to dissect if myofibroblasts
retain a memory of their original lineage identity, and whether all
myofibroblasts are equally able to convert into specific cell fates
when exposed to a particular microenvironment. Also, our cur-
rent understanding about fibroblast heterogeneity in skin fibrosis
is only being inferred from the wound-associated scarring pro-
cess, but ideally, future work profiling of fibroblast subsets in
mouse models of skin disease and human lesions will be infor-
mative about differences in manageable versus pathological
fibrosis.
Lung Connective tissue in the lung includes a diverse collection
of mesenchymal cell populations: airway smooth muscle, vascu-
lar smooth muscle, pericytes surrounding the abundant blood
vessels and fibroblasts. To dissect mesenchymal cell heterogene-
ity in lung homeostasis, Zepp et al. combined histological anal-
ysis of cell signalling reporters for PDGFRα, Wnt2 and Axin2
with single-cell RNA-seq, ultimately stratifying the cell popula-
tions spatially and functionally [38••]. Five key subpopulations
were identified transcriptionally, which nicely overlapped with
the reporters used, but the spatial distribution really helped illu-
minate their distinct functions. PDGFRα+ cells were generally
found in the alveolar niche, versus PDGFRα− in the vicinity of
airways and blood vessels. This binary grouping could be further
subdivided; PDGFRα+/Axin2+ cells (designated “MANCs”,
mesenchymal alveolar niche cells) were particularly important
for alveolar epithelial cell growth and self-renewal, whereas
PDGFRα−/Axin2+ defined a myofibrogenic progenitor popula-
tion, which were major contributors to pathogenic
myofibroblasts after injury (described below). With a similar
approach, Lee et al. revealed that Lgr5 and Lgr6 expression
defines two spatially and functionally distinct populations in
the healthy mouse lung mesenchyme [39]. Comparably with
Zepp et al., a population located in the alveolar niche emerged
(which here was Lgr5+), as well as an Lgr6+ smooth muscle cell
subpopulation in the airway compartment. The authors consid-
ered their Lgr5+ cells partially overlapping with the PDGFRα+/
Axin2+ MANCs described above, and the Lgr6-expressing
smooth muscle cell subpopulation is anticipated to be a progeny
of Axin2+ progenitors close to the airways. Adding to the cellu-
lar complexity, lipofibroblasts are another distinct cell population
detected by Xie et al. in their single-cell RNA-seq analysis of
healthy mouse lung tissue [40]. These are lipid-containing inter-
stitial fibroblasts anticipated to be important for alveolar devel-
opment and regeneration [41].
It is not yet clear how the subpopulations identified in
mouse will map onto the human lung; however, single-cell
analysis on healthy human lungs has identified two major
(SPINT2 high and MFAP5 high) and one minor (WIF1 high)
groupings [42••]. Divergent transcriptional profiles, including
variable expression of ECM genes, infer distinct functionality
that may correlate with MANCs or airway smooth muscle
cells described in mouse, but additional localisation and func-
tional assays are needed. There was no evidence of
lipofibroblasts in this study, suggesting that this cell designa-
tion may not be detected in normal human lungs, or at least in
the region biopsied.
Lung fibrosis, characterised by progressive and unrelenting
ECM deposition, is a feature of multiple diseases (e.g. idio-
pathic pulmonary fibrosis (IPF), systemic sclerosis). Research
on this topic commonly uses a bleomycin-induced mouse
model. Peyser et al. isolated fibroblasts for single-cell
RNA-seq in the early disease stage, and perhaps as expect-
ed, observed a significant increase in the proportion of
cells in an “activate fibroblast” cluster [43•]. Importantly
however, they showed that fibroblast number was not in-
creased at this stage, fibroblast heterogeneity persisted in
the fibrotic lungs and none of the signature genes in the
activated cluster were exclusive. Notably, Acta2 (the gene
encoding α-smooth-muscle-actin, αSMA) and TGFβ
signalling-associated genes were only upregulated in a
subset of “activated cells”, illustrating that an inclusive
approach considering all of the parameters influencing
their phenotype (Fig. 1a) is needed to capture the complex-
ity of activated fibroblasts. A similar single-cell RNA-seq
study identified an additional profibrotic population with
high PDGFRβ expression [44]. Although PDGFRβ is
known as a pericyte marker, trajectory analysis and direct
comparisons of the transcriptional signatures suggest that
lipofibrobasts are their major source.
Ageing seems to add another layer of complexity to lung
fibrosis (Fig. 1b). Comparison of bleomycin-induced fibrosis
in young and old mice revealed that with age, myofibroblasts
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acquire an apoptosis-resistant phenotype that is mediated by
sustained activation of NADPH oxidase 4 (Nox4) leading to a
redox imbalance and impaired induction of an Nrf2 anti-
oxidative response [45]. Pharmacological Nox4 inhibition
was able to resensitise myofibroblasts to apoptosis, thus re-
ducing the duration of fibrosis in aged mice, and in turn
prolonging their survival after lung injury. These find-
ings could be extrapolated to human IPF tissue, which
also showed a redox imbalance mediated by the same
molecular mechanisms.
The cell composition in human lung fibrosis has been stud-
ied by comparing systemic sclerosis (SSc) lungs to healthy
controls [42••]. This study detected a disease-associated, ac-
tively proliferating myofibroblast population that is thought to
have undergone significant phenotypic changes during dis-
ease development, including upregulation of collagens and
other profibrotic genes. Despite dramatic differentiation, the
transcriptional signature was sufficiently consistent with only
one of the two major cell populations in the healthy lung
(MFAP5+) so that descent from this lineage could be predict-
ed [42••]. Following a similar approach to dissect the stroma
of human lung tumours at single-cell resolution, five distinct
fibroblast subpopulations have been revealed with unique rep-
ertoires of ECMmolecules [46]. It will be interesting to apply
the proposed fibroblast stratification strategies (Fig. 1) to com-
pare the cellular composition and relative fibroblast contribu-
tions of tumour-associated desmoplasia with other fibrotic le-
sions, in order to understand the influence of the cancer cell
themselves and the special immune microenvironment.
Liver The fibroblasts of the liver, hepatic stellate cells (HSC)
and portal fibroblasts, comprise approximately 15% of the
total cells in the organ [47]. In homeostasis, HSCs are gener-
ally quiescent, residing in a special connective tissue space
(space of Disse) between the sinusoids and the hepatocytes,
where they play important roles in structural support and stor-
ing vitamin A. In contrast, portal fibroblasts do not store vita-
min A lipids and are located around the bile duct in the portal
tract, expressing characteristic markers including COL15A1,
elastin and ectonucleoside triphosphate diphosphohydrolase-2
[13]. Both cell types can be activated by numerous physical
and chemical insults and, when chronically activated, are key
culprits of liver fibrosis. Notably, a lineage tracing study la-
belling myofibroblasts using col1a1 promoter reported that
HSCs were the major source of myofibroblasts (> 87%) in a
chemical injury mouse model (carbon tetrachloride), whereas
portal fibroblasts contributed predominantly tomyofibroblasts
(> 70%) in an early stage of cholestatic injury (bile duct liga-
tion) [48].
Research of liver fibroblast heterogeneity is making signif-
icant headway into understanding how the different layers of
complexity manifest in this organ system (Fig. 1a). For exam-
ple, developmental HSC diversity was discovered by lineage-
tracing Wilms’ Tumour 1 (WT1)-positive cells (which labels
mesothelium) from development through to adulthood [49•].
This revealed two subpopulations of quiescent HSCs in
healthy adult liver, one positive for the WT1 lineage and one
negative, which have strikingly divergent transcriptomes and
distinct contributions to liver fibrosis. Specifically,
mesothelium-derived (WT1-lineage) cells were the major
contributing cells to fibrotic lesions in numerous injury
models. Interestingly, re-expression of WT1 in response to
tissue damage (i.e. cells re-enacting their developmental gene
expression signature) promoted cell de-differentiation/plastic-
ity, and conversely, WT1 loss facilitated myofibroblast differ-
entiation [49•].
Single-cell RNA-seq of adult mouse liver without stratifying
on developmental origin provides a different perspective
(Fig. 1b). Dobie et al. analysed PDGFRβ-positive cells (antici-
pated to label all mesenchymal cells) from healthy adult mouse
liver and identified two mesenchymal populations (in addition to
vascular smooth muscle cells), which they designated as HSCs
(enriched for vitamin A–associated genes) and fibroblasts
(enriched for ECM genes) [50•]. Interestingly, the authors also
demonstrated regional heterogeneity of the HSCs, with
transcriptomes varying with respect to proximity to the portal
versus central vein. They identified that central vein–associated
HSCs were the dominant pathogenic collagen-producing cells in
a chemical injury model. Notably, these activated HSCs
expressed high levels of lysophosphatidic acid receptor 1
(LPAR1), a G protein–coupled receptor that binds to lipid-
signalling molecule LPA, and pharmacological inhibition signif-
icantly inhibited liver fibrosis. The site-specific features of the
tissue influencing the cell phenotype (e.g. hypoxia [51]) will be
interesting to understand (Fig. 1a) and may help to optimise anti-
fibrotic therapies in the future. A similar single-cell RNA-seq
study unveiled additional diversity within the activated HSC
population [52]. Both an in vivo (carbon tetrachloride) and an
in vitro (cultivation on plastic with serum) model resulted in four
clusters of activated cells. S100A6 expression was shared across
all populations, but the different groups varied in αSMA, colla-
gens, immunological markers and stress-response genes, sug-
gesting they may make unique contributions to fibrosis (as pro-
posed in Fig. 1b) worth dissecting in the future.
A single-cell RNA-seq study of healthy versus cirrhotic human
liver aiming to define alterations in niche components and signal-
ling interactions in fibrotic disease uncovered four distinct mesen-
chymal clusters: vascular smooth muscle (MYH11), hepatic stel-
late (RGS5 high), mesothelial cells and SAMes (scar-associated
mesothelial) cells [53••]. Notably, SAMes cells were expanded in
cirrhotic livers and showed high expression of PDGFRα, fibrillar
collagens and other pro-fibrotic genes, many of which are con-
served from mouse [54]. Further clustering of SAMes cells re-
vealed two subpopulations distinguished by OSR1 expression
(odd-skipped related 1 transcription factor), which labelled
periportal cells in healthy liver as well as cells in fibrotic lesions.
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This is additional evidence that, although they have some impor-
tant distinct features, regional subpopulations (e.g. portal versus
central) all have the potential to contribute to disease (Fig. 1b).
Kidney During kidney development in mouse and human,
nephron patterning involves mesenchymal progenitor cell re-
cruitment into the epithelial nephron precursor [55]. Lineage
tracing experiments have shown that almost all kidney fibro-
blasts are derived from neural crest cells as they are lineage-
labelled with myelin protein zero (P0) [56]. In adult homeo-
stasis, fibroblasts reside in the renal interstitium and assume an
interesting organ-specific function of erythropoietin expres-
sion. Resident fibroblasts also wrap around peritubular capil-
laries to provide stability to the vasculature, where they are
thought to overlap considerably with pericytes. Upon acute
kidney injury (AKI), fibroblasts detach from the capillaries
and migra te to the s i te of damage , where they
transdifferentiate to myofibroblasts, losing erythropoietin ex-
pression but gaining the ability to secrete scar-associated
ECM (reviewed in [57]). If the damage is repeated or persis-
tent, or particularly severe, AKI can progress to chronic kid-
ney disease, with organ fibrosis as a hallmark of this scenario.
Although single-cell RNA-seq analysis has been per-
formed on mouse and human kidney tissue in development
and disease, generating a comprehensive cell atlas, the mes-
enchymal cell heterogeneity and in particular its functional
significance in fibrosis remain poorly defined [58•, 59, 60••].
Stratifying the fibroblasts based on the four proposed vari-
ables and considering the dynamic changes in health and dis-
ease could help to provide more insights into these single-cell
datasets (Fig. 1).
Genetic lineage tracing experiments indicate that both res-
ident fibroblasts and pericytes are precursors to the
myofibroblasts that produce the bulk of the scar matrix. The
picture is emerging that, beyond ECM deposition, resident
fibroblasts display pro-inflammatory phenotypes upon tissue
injury and even become inflammatory effector cells, by acti-
vating NF-κB signalling and secreting pro-inflammatory cy-
tokines (reviewed in [61]). Curiously, with age, acute injury
can lead to the development of tertiary lymphoid tissue within
the kidney, suggesting age-dependent variations in the plas-
ticity and fate of the pathological cell phenotype. Sato et al.
discovered that only in aged mice fibroblasts could be strati-
fied based on their localisation (i.e. within the tertiary lym-
phoid tissue versus in the surrounding areas) [62]. These two
distributions were associated with different gene expression
and function, with the surrounding cells expressing the ma-
chinery to produce retinoic acid, and the activated fibroblasts
within the tertiary lymphoid tissue sustaining inflammation
and impeding tissue repair. Interestingly, the fibroblast subset
within the lymphoid territories expressed p75 neurotrophin
receptor (NTR), a neural crest marker. Reinstatement of this
marker that reflects the cells’ developmental origin is
reminiscent of the WT1+ induction by activated HSCs in the
liver [49•], which may indicate a de-differentiation process
with an accompanying increase in plasticity. Indeed, these
NTR+ cells are remarkably plastic, capable of maturing into
CD21/CXCL13-positive follicular dendritic cells within this
specialist tissue niche.
Heart Cardiac fibroblasts represent ~10–20% of all cardiac
cells in adult mice and are distributed throughout the intersti-
tial, perivascular and sub-epicardial spaces [63]. Similar to
fibroblasts in other organs, it is very difficult to clearly define
a fibroblast in the cardiac tissue because common markers
such as CD90 (Thy1), FSP1 (fibroblast-specific protein 1) or
vimentin are also expressed by many other cell types
(reviewed in [64]). In mice, PDGFRα seems to be the most
reliable pan-fibroblast marker in the adult heart. In homeosta-
sis, cardiac fibroblasts have diverse functionality, providing
important paracrine signals, ECM that has structural, mechan-
ical, electrically insulating functions, and also responding in
the event of tissue injury. Therefore, it is predictable that,
amongst the fibroblasts that specialise to fulfil this range of
tasks, there will be heterogeneous subsets defined by the four
variables (Fig. 1a).
Developmentally, there are two main sources of fibroblasts
that were revealed by lineage-tracing which somewhat segre-
gate by location [65, 66]. Location within the heart is indeed
expected to be an important regional variable strongly
influencing (and reflecting) the resident fibroblasts; for exam-
ple, the valves compared with the ventricular walls have re-
markably different cellular composition, mechanical proper-
ties, metabolic demands and susceptibility to damage [15]. A
single-cell RNA-seq analysis identified two major fibroblast
populations in adult mouse ventricles; however, the distribu-
tion of expression of an epicardium marker amongst the cells
indicated that these clusters do not reflect the two developmen-
tal origins [67•]. Similarly, a single-nucleus transcriptomic
approach of early postnatal heart tissue identified two fibro-
blast populations that were actually only subtly different and
both expressed high levels of specific ECM genes (periostin,
fibrillin 1 and collagen 5a1) [68]. Further exploration into the
overlap, sub-clustering and differing functions of these popu-
lations is warranted. Another single-cell RNA-seq analysis on
all interstitial cell populations in the ventricles identified five
relevant fibroblast cell populations in homeostasis: Sca1-low
and Sca1-high, Wnt-expressing, myofibroblasts and activated
fibroblasts [69••]. To better dissect the heterogeneity of these
cells, the authors focussed on the PDGFRα-positive lineages.
This actually exposed 11 populations, including subtypes
expressing pro- and anti-fibrotic gene signatures, and two pre-
viously unrecognised groups, Wnt-expressing cells (which
have enrichment of both positive and negative regulators of
the pathway and are predicted to have anti-fibrotic and angio-
genesis function) and transitory cells (predicted to be
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transitioning fromWnt-expressing to Sca1-low fibroblasts that
have an intriguing secretory phenotype). Although more
research on their distinct functionalities is required, some pre-
dictions on the roles of the 11 different populations could be
inferred by the gene expression profiles and abundance at rest
and following myocardial infarction (MI).
MI injury causes acute necrosis of cardiomyocytes, which
then initiates a tissue repair response that inevitably forms a
scar. Due to its lack of contractility and altered mechanical
properties, the scar tissue severely compromises functionality
of the organ. Although the scar is far from perfect, it is essen-
tial since fibroblast depletion using diphtheria toxin prior to
MI injury leads to increased lethality because of inefficient
collagen production and ventricular rupture [70]. It seems
there is a balance to be struck between sufficient repair but
minimised fibrosis; an understanding of the diverse fibroblasts
that contribute to repair has the potential to uncover strategies
to manipulate certain subsets to dampen the fibrotic response.
Single-cell RNA-seq time-course experiments after MI injury
in mice indicate that approximately 50% of cardiac fibroblasts
become activated and start to express αSMA [69••]. It is
thought that all cardiac fibroblast populations can contribute
to the activated pool, and the scale suggests that it also extends
beyond the infarcted area. Trajectory analysis of this time
course of repair showed that the “activated” fibroblast popu-
lation peaked in numbers at 3 days post-injury and could be
split into three clusters: a non-proliferative, a cycling and a
cluster transitioning between the two. The transcriptome of the
non-proliferative but activated fibroblasts was most similar to
the resting population, pointing to a gradual transition towards
a myofibroblast fate. Fully differentiated myofibroblasts with
stereotypical expression profiles including cell adhesion,
ECM remodelling and angiogenesis genes dominated only at
7 days post-injury and also further divided into three obvious
subpopulations. Two groups had high Tgfb1, Scx and Thbs4
expression, which are known drivers of cardiac fibrosis, but
the third population expressed high level of anti-fibrosis genes
including Wisp2, Sfrp2, Htra1 and Htra3, indicating that they
will have contrasting functions in fibrosis. This is another
prominent example of how fibroblast heterogeneity is able
to dynamically change in disease conditions (Fig. 1b).
Although heart fibrosis is generally thought of as irreversible,
some degree of resolution can be observed after acute injury and
its subsequent repair process. In addition to apoptosis, lineage
tracing experiments indicate that myofibroblasts can revert back
to a less activated state [70] and acquire a new and stable differ-
entiated status designated matrifibrocytes [71]. These express an
ECM gene signature reminiscent of tendon, which is anticipated
to promote a mature scar. Harnessing this cell plasticity may be
therapeutically valuable.
Conclusion and Future Outlook
Tissue analysis at a single-cell resolution has opened up
incredible new insights into the cellular heterogeneity of
different organs, and particularly an unexpected diversi-
ty amongst the fibroblasts. With sequencing costs de-
creasing and the sensitivity and sequencing depth in-
creasing, we can expect numerous publications
uncovering more and more subpopulations of fibroblasts
in all tissues (e.g. including synovium or bone-marrow
[72, 73]). New strategies to stratify fibroblasts that are
guided by their functional diversity rather than the ex-
pression of specific marker genes are essential to under-
stand and compare fibroblast heterogeneity in different
organ systems and across species (Fig. 1).
We are only at the beginning of understanding the
functional relevance of this heterogeneity for organ
function in homeostasis and disease, and the challenges
are numerous. Manipulating specific fibroblast types
in vivo is technically challenging due to the lack of
specific drivers, since so many of the genes expressed
are overlapping. Also, although it may be possible to
isolate the subpopulations using multiple markers, their
phenotype may not be stable in culture conditions [23•,
74, 75]. Additional insight into subpopulation function-
ality may be gleaned from positional information, but
this is lacking from most single-cell studies to date.
Optimistically, new spatial transcriptomic technology is
anticipated to bridge this knowledge gap [76, 77].
Indeed, the Human Cell Atlas initiative includes within
their objectives the mapping of single cells within their
tissue (https://www.humancellatlas.org/). Finally,
translating the discoveries in animal models to the
human setting is a difficult hurdle. Mouse work is
impressively establishing the trajectory of certain cell types
towards a pathological phenotype, but this is very difficult to
replicate in human tissues, where we can typically only
analyse the beginning (healthy tissue) and the end (advanced
disease), and even that is usually with tissue from different
individuals. However, a recent attempt to analyse the
developmental trajectory of renal tumours in humans has
produced promising results [60••].
Many of us hypothesise that there will be certain fibro-
blast subsets particularly responsible for driving fibrotic
disease, and in turn believe that therapeutically manipu-
lating the identity, behaviour or even survival of specific
cells could be beneficial in treating these conditions.
Therefore, motivation is high to push technical limits in
order to understand the extrinsic and intrinsic mechanisms
underlying the establishment and persistence of fibro-
blasts causative of pathological fibrosis.
Page 7 of 10     33Curr Rheumatol Rep (2020) 22: 33
Acknowledgements The authors would like to thank Dr. Kalle Sipilä
(King’s College London) for critically reading the manuscript.
Funding Information This study received funding support from the
EMBO Advanced Fellowship program (E.R., aALTF 523-2017).
Compliance with Ethical Standards
Conflict of Interest The authors declare that they have no conflict of
interest.
Human and Animal Rights and Informed Consent This article does not
contain any studies with human or animal subjects performed by any of
the authors.
Open Access This article is licensed under a Creative Commons
Attribution 4.0 International License, which permits use, sharing, adap-
tation, distribution and reproduction in any medium or format, as long as
you give appropriate credit to the original author(s) and the source, pro-
vide a link to the Creative Commons licence, and indicate if changes were
made. The images or other third party material in this article are included
in the article's Creative Commons licence, unless indicated otherwise in a
credit line to the material. If material is not included in the article's
Creative Commons licence and your intended use is not permitted by
statutory regulation or exceeds the permitted use, you will need to obtain
permission directly from the copyright holder. To view a copy of this
licence, visit http://creativecommons.org/licenses/by/4.0/.
References
Papers of particular interest, published recently, have been
highlighted as:
• Of importance
•• Of major importance
1. He S, Sharpless NE. Senescence in health and Disease. Cell
2017;169:1000–11.
2. Takahashi K, Yamanaka S. Induction of pluripotent stem cells from
mouse embryonic and adult fibroblast cultures by defined factors.
Cell. 2006;126:663–76.
3. Shaw TJ,Martin P.Wound repair: a showcase for cell plasticity and
migration. Curr Opin Cell Biol. 2016;42:29–37.
4. Barallobre-Barreiro J, Woods E, Bell RE, Easton JA, Hobbs C,
Eager M, et al. Cartilage-like composition of keloid scar extracel-
lular matrix suggests fibroblast mis-differentiation in disease.
Matrix Biol Plus. 2019;4:100016.
5. McCulley D, Wienhold M, Sun X. The pulmonary mesenchyme
directs lung development. Curr Opin Genet Dev. 2015;32:98–105.
6. Gieniec KA, Butler LM, Worthley DL, Woods SL. Cancer-associ-
ated fibroblasts—heroes or villains? Br J Cancer. 2019;121:293–
302.
7. LeBleu VS, Kalluri R. A peek into cancer-associated fibroblasts:
origins, functions and translational impact. DMMDisModelMech.
2018;11:1–9.
8. Fitzgerald O’Connor EJ, Badshah, II, Addae LY, Kundasamy P,
Thanabalasingam S, Abioye D, Soldin M, Shaw TJ. Histone
deacetylase 2 is upregulated in normal and keloid scars. J Invest
Dermatol. 2012.;132:1293–6.
9. Rinkevich Y, Walmsley GG, Hu MS, Maan ZN, Newman AM,
Drukker M, et al. Identification and isolation of a dermal lineage
with intrinsic fibrogenic potential. Science. 2015;348:aaa2151.
10. Sorrell JM. Fibroblast heterogeneity: more than skin deep. J Cell
Sci. 2004;117:667–75.
11. Fries KM, Blieden T, Looney RJ, Sempowski GD, Silvera MR,
Willis RA, et al. Evidence of fibroblast heterogeneity and the role
of fibroblast subpopulations in fibrosis. Clin Immunol
Immunopathol. 1994;72:283–92.
12. Ballardini G, Groff P, de Giorgi LB, Schuppan D, Bianchi FB. Ito
cell heterogeneity: desmin-negative ito cells in normal rat liver.
Hepatology. 1994;19:440–6.
13. Dranoff JA, Wells RG. Portal fibroblasts: underappreciated media-
tors of biliary fibrosis. Hepatology. 2010;51:1438–44.
14. Kotaru C, Schoonover KJ, Trudeau JB, Huynh ML, Zhou XX,
Hu H, et al. Regional fibroblast heterogeneity in the lung:
implications for remodeling. Am J Respir Crit Care Med.
2006;173:1208–15.
15. Ivey MJ, Tallquist MD. Defining the cardiac fibroblast. Circ J.
2016;80:2269–76.
16. Rognoni E, Gomez C, Pisco AO, Rawlins EL, Simons BD, Watt
FM, et al. Inhibition of β-catenin signalling in dermal fibroblasts
enhances hair follicle regeneration during wound healing.
Development. 2016;143:2522–35.
17. Rognoni E, Watt FM. Skin cell heterogeneity in development,
wound healing, and cancer. Trends Cell. 2018;28:709–22.
18.• Rognoni E, Oliveira Pisco A, Hiratsuka T, Sipilä K, Belmonte J,
Mobasseri SA, et al. Fibroblast state switching orchestrates dermal
maturation and wound healing. Mol Syst Biol. 2018;14(8):e8174.
Combining cell biology techniques andmathematicalmodeling,
this study elucidates for the first time how the tissue-scale coor-
dination of skin fibroblast is achieved during development and
tissue repair.
19. Driskell RR, Lichtenberger BM, Hoste E, Kretzschmar K, Simons
BD, Charalambous M, et al. Distinct fibroblast lineages determine
dermal architecture in skin development and repair. Nature
2013;504:277–81.
20. Jiang D, Correa-Gallegos D, Christ S, Stefanska A, Liu J, Ramesh
P, et al. Two succeeding fibroblastic lineages drive dermal devel-
opment and the transition from regeneration to scarring. Nat Cell
Biol. 2018;20:422–31.
21.• Joost S, Annusver K, Jacob T, Sun X, Dalessandri T, Sivan U,
Sequeira I, Sandberg R, Kasper M. The Molecular Anatomy of
Mouse Skin during Hair Growth and Rest. Cell Stem Cell.
2020;26:441-57.e7. This mouse skin single cell RNA-seq study
uncovered the spatiotemporal fibroblast heterogeneity during
different hair growth stages demonstrating the importance of
the tissue state.
22.• Tabib T,Morse C,Wang T, ChenW, Lafyatis R. SFRP2/DPP4 and
FMO1/LSP1 define major fibroblast populations in human skin. J
Invest Dermatol. 2018;138(4):802–10. Using a single-cell ap-
proach, this is one of the first studies extensively profiling fibro-
blast heterogeneity in healthy human skin.
23.• Philippeos C, Telerman S, Oulès B, Pisco AO, Shaw TJ, Elgueta R,
et al. Spatial and single-cell transcriptional profiling identifies func-
tionally distinct human dermal fibroblast subpopulations. J Invest
Dermatol. 2018;138(4):811–25. This single-cell study
characterises the functional and spatial heterogeneity of dermal
fibroblasts in the human and mouse skin.
24. Solé-Boldo L, Raddatz G, Schütz S, Mallm JP, Rippe K, Lonsdorf
AS, Rodríguez-Paredes M, Lyko F. Single-cell transcriptomes of
the human skin reveal age-related loss of fibroblast priming.
Commun Biol. 2020;3:188.
25. Vorstandlechner V, Laggner M, Kalinina P, Haslik W, Radtke C,
Shaw L, et al. Deciphering the functional heterogeneity of skin
33    Page 8 of 10 Curr Rheumatol Rep (2020) 22: 33
fibroblasts using single-cell RNA sequencing. FASEB J. 2020;34:
3677–92.
26. Thulabandu V, Chen D, Atit RP. Dermal fibroblast in cutaneous
development and healing. Wiley Interdiscip Rev Dev Biol. 2018;7:
1–13.
27. Shaw TJ, Martin P. Wound repair at a glance. J Cell Sci. 2009;122:
3209–13.
28. Marangoni RG, Korman BD, Wei J, Wood TA, Graham LV,
Whitfield ML, et al. Myofibroblasts in murine cutaneous fibrosis
originate from adiponectin-positive intradermal progenitors.
Arthritis Rheum. 2015;67:1062–73.
29. Correa-Gallegos D, Jiang D, Christ S, Ramesh P, Ye H,
Wannemacher J, et al. Patch repair of deep wounds by mobilized
fascia. 2019;576:287–92.
30. Kaushal GS, Rognoni E, Lichtenberger BM, Driskell RR,
Kretzschmar K, Hoste E, et al. Fate of prominin-1 expressing der-
mal papilla cells during homeostasis, wound healing and wnt acti-
vation. 2015;135:2926–34.
31. Dulauroy S, Di Carlo SE, Langa F, Eberl G, Peduto L. Lineage
tracing and genetic ablation of ADAM12 + perivascular cells iden-
tify a major source of profibrotic cells during acute tissue injury.
Nat Med. 2012;18:1262–70.
32.• Guerrero-juarez CF, Dedhia PH, Jin S, Ruiz-vega R, Ma D, Liu Y,
et al. Single-cell analysis reveals fibroblast heterogeneity and mye-
loid-derived adipocyte progenitors in murine skin wounds. Nat
Commun. 2019;10:650. This single cell study explores the diver-
sity of activated fibroblasts in skin wounds in new detail.
33.• Shook BA, Wasko RR, Rivera-Gonzalez GC, Salazar-Gatzimas E,
López-Giráldez F, Dash BC, et al. Myofibroblast proliferation and
heterogeneity are supported by macrophages during skin repair.
Science. 2018;362:eaar2971. This study identifies a selective
crosstalk between a specific macrophage and fibroblast sub-
population during wound repair and fibrosis, providing a
prominent example of how functional heterogeneity is regulat-
ed at the cellular level within a tissue.
34. Salzer MC, Lafzi A, Berenguer-Llergo A, Youssif C, Castellanos
A, Solanas G, et al. Identity noise and adipogenic traits characterize
dermal fibroblast aging. 2018;175:1575–90.
35.• Hiebert P, Wietecha MS, Cangkrama M, Haertel E, Mavrogonatou
E, StumpeM, et al. Nrf2-mediated fibroblast reprogramming drives
cellular senescence by targeting the matrisome. Dev Cell. 2018;46:
145–161.e10. This study identifies how activation of Nrf2 in
fibroblasts promotes cellular senescence through production
of a senescence-promoting matrisome showing impressively
the rec iproca l r egu la t i on o f c e l l u l a r s ta t e and
microenvironment.
36. Plikus MV, Guerrero-Juarez CF, Ito M, Li YR, Dedhia PH, Zheng
Y, et al. Regeneration of fat cells from myofibroblasts during
wound healing. Science. 2017;355:748–52.
37. Lim CH, Sun Q, Ratti K, Lee SH, Zheng Y, Takeo M, et al.
Hedgehog stimulates hair follicle neogenesis by creating inductive
dermis during murine skin wound healing. Nat Commun. 2018;9:
4903.
38.•• Zepp JA, Zacharias WJ, Frank DB, Cavanaugh CA, Zhou S,
Morley MP, et al. Distinct mesenchymal lineages and niches pro-
mote epithelial self-renewal and myofibrogenesis in the lung. Cell.
2017;170:1134–48.e10. By combining histological and single
cell transcriptomic analysis, this study elegantly uncovers the
cellular heterogeneity of within alveolar and airway mesenchy-
mal niche in the mouse lung.
39. Lee JH, Bhang DH, Beede A, Huang TL, Stripp BR, Bloch KD,
et al. Lung stem cell differentiation in mice directed by endothelial
cells via a BMP4-NFATc1-thrombospondin-1 axis. Cell. 2014;156:
440–55.
40. Xie T, Wang Y, Deng N, Huang G, Taghavifar F, Geng Y, et al.
Single-cell deconvolution of fibroblast heterogeneity in mouse pul-
monary fibrosis. Cell Rep. 2018;22:3625–40.
41. Tahedl D, Wirkes A, Tschanz SA, Ochs M, Mühlfeld C. How
common is the lipid body-containing interstitial cell in the mamma-
lian lung? Am J Phys Lung Cell Mol Phys. 2014;307:386–94.
42.•• Valenzi E, Bulik M, Tabib T, Morse C, Sembrat J, Trejo Bittar H,
et al. Single-cell analysis reveals fibroblast heterogeneity and
myofibroblasts in systemic sclerosis-associated interstitial lung dis-
ease. Ann Rheum Dis. 2019;78:1379–87. This single-cell RNA-
seq study elucidates for the first time the fibroblast heterogene-
ity in human lungs by comparing systemic sclerosis (SSc) with
healthy control tissue.
43.• Peyser R, MacDonnell S, Gao Y, Cheng L, Kim Y, Kaplan T, et al.
Defining the activated fibroblast population in lung fibrosis using
single-cell sequencing. Am J Respir Cell Mol Biol. 2019;61:74–85.
This time course study of a mouse lung fibrosis model provides
important insights into the diversity and dynamic changes of
activated fibroblast at a single-cell level.
44. El Agha E, Moiseenko A, Kheirollahi V, De Langhe S,
Crnkovic S, Kwapiszewska G, et al. Two-way conversion be-
tween lipogenic and myogenic fibroblastic phenotypes marks
the progression and resolution of lung fibrosis. Cell Stem Cell.
2017;20:261–273.e3.
45. Hecker L, Logsdon NJ, Kurundkar D, Kurundkar A, Hock T,
Meldrum E, et al. Reversal of persistent fibrosis in aging by
targeting Nox4-Nrf2 redox imbalance. Sci Transl Med.
2014;6(231):231ra47.
46. Lambrechts D,Wauters E, BoeckxB, Aibar S, Nittner D, Burton O,
et al. Phenotype molding of stromal cells in the lung tumor micro-
environment. Nat Med. 2018;24:1277–89.
47. Higashi T, Friedman SL, Hoshida Y. Hepatic stellate cells as key
target in liver fibrosis. Adv Drug Deliv Rev. 2017;121:27–42.
48. Iwaisako K, Jiang C, Zhang M, Cong M, Moore-Morris TJ, Park
TJ, et al. Origin of myofibroblasts in the fibrotic liver in mice. Proc
Natl Acad Sci U S A. 2014;111:E3297–305.
49.• Kendall TJ, Duff CM, Boulter L, Wilson DH, Freyer E, Aitken S,
et al. Embryonic mesothelial-derived hepatic lineage of quiescent
and heterogenous scar-orchestrating cells defined but suppressed by
WT1. Nat Commun 2019;10:4688. This study combines lineage
tracing and transcriptomic analysis to explore the HSC diver-
sity in development and fibrosis of the mouse liver.
50.• Dobie R, Wilson-Kanamori JR, Henderson BEP, Smith JR,
Matchett KP, Portman JR, et al. Single-cell transcriptomics un-
covers zonation of function in the mesenchyme during liver fibro-
sis. Cell Rep. 2019;29:1832–47.e8. This single-cell RNA-seq
study uncovers spatial and functional zonation of HCSs in the
mouse liver and explores the relevance for homeostasis and
fibrosis.
51. Kietzmann T. Metabolic zonation of the liver: the oxygen gradient
revisited. Redox Biol. 2017;11:622–30.
52. Krenkel O, Hundertmark J, Ritz TP, Weiskirchen R, Tacke F.
Single cell RNA sequencing identifies subsets of hepatic stellate
cells and myofibroblasts in liver fibrosis. Cells. 2019;8:503.
53.•• Ramachandran P, Dobie R, Wilson-Kanamori JR, Dora EF,
Henderson BEP, Luu NT, et al. Resolving the fibrotic niche of
human liver cirrhosis at single-cell level. Nature. 2019;575:512–
18. This is the first study revealing regional differences at a
single-cell level in human liver fibrosis which was previously
only observed in mice.
54. DeMinicis S, Seki E, UchinamiH, Kluwe J, ZhangY, Brenner DA,
et al. Gene expression profiles during hepatic stellate cell activation
in culture and in vivo. Gastroenterology. 2007;132:1937–46.
55. Lindström NO, De Sena BG, Tran T, Ransick A, Suh G, Guo J,
et al. Progressive recruitment of mesenchymal progenitors reveals a
Page 9 of 10     33Curr Rheumatol Rep (2020) 22: 33
time-dependent process of cell fate acquisition in mouse and human
nephrogenesis. Dev Cell. 2018;45:651–60.e4.
56. Asada N, Takase M, Nakamura J, Oguchi A, Asada M, Suzuki N,
et al. Dysfunction of fibroblasts of extrarenal origin underlies renal
fibrosis and renal anemia in mice. J Clin Invest. 2011;121:3981–90.
57. Sato Y, Yanagita M. Functional heterogeneity of resident fibro-
blasts in the kidney. Proc Japan Acad Ser B Phys Biol Sci.
2019;95:468–78.
58.• Park J, Shrestha R, Qiu C, Kondo A, Huang S, Werth M, et al.
Single-cell transcriptomics of the mouse kidney reveals potential
cellular targets of kidney disease. Science. 2018;360:758–63. This
single-cell study provides a comprehensive cell atlas that gives
valuable insights into kidney function and disease pathogenesis.
59. Liao J, Yu Z, Chen Y, Bao M, Zou C, Zhang H, et al. Single-cell
RNA sequencing of human kidney. Sci Data. 2020;7:4.
60.•• YoungMD, Mitchell TJ, Vieira Braga FA, TranMGB, Stewart BJ,
Ferdinand JR, et al. Single-cell transcriptomes from human kidneys
reveal the cellular identity of renal tumors. Science. 2018;361:594–
9. This impressive single-cell transcriptomic study combines
human renal tumours and normal tissue from fetal, pediatric
and adult kidneys to elucidate the identity and composition of
these tumours.
61. Hatanaka F, Ocampo A, Izpisua Belmonte JC. Keeping the rhythm
while changing the lyrics: circadian biology in aging. Cell.
2017;170:599–600.
62. Sato Y, Mii A, Hamazaki Y, Fujita H, Nakata H, Masuda K, et al.
Heterogeneous fibroblasts underlie age-dependent tertiary lym-
phoid tissues in the kidney. JCI Insight. 2016;1:e87680.
63. Pinto AR, Ilinykh A, Ivey MJ, Kuwabara JT, D’antoni ML,
Debuque R, et al. Revisiting cardiac cellular composition. Circ
Res. 2016;118:400–9.
64. Tallquist MD, Molkentin JD. Redefining the identity of cardiac
fibroblasts. Nat Rev Cardiol. 2017;14:484–91.
65. Acharya A, Baek ST, Huang G, Eskiocak B, Goetsch S, Sung CY,
et al. The bHLH transcription factor Tcf21 is required for lineage-
specific EMT of cardiac fibroblast progenitors. Development.
2012;139:2139–49.
66. Huang X, Feng T, Jiang Z, Meng J, Kou S, Lu Z, et al. H. Dual
lineage tracing identifies intermediate mesenchymal stage for endo-
cardial contribution to fibroblasts, coronary mural cells, and adipo-
cytes. J Biol Chem. 2019;294:8894–906.
67.• Skelly DA, Squiers GT, MA ML, Bolisetty MT, Robson P,
Rosenthal NA, et al. Single-cell transcriptional profiling reveals
cellular diversity and intercommunication in the mouse heart.
Cell Rep. 2018;22:600–10. This is a comprehensive single-cell
transcriptome study profiling the heterogeneity of the non-
myocyte cells in the adult mouse heart.
68. Hu P, Liu J, Zhao J, Wilkins BJ, Lupino K, Wu H, et al. Single-
nucleus transcriptomic survey of cell diversity and functional mat-
uration in postnatal mammalian hearts. Genes Dev. 2018;32:1344–
57.
69.•• Farbehi N, Patrick R, Dorison A, Xaymardan M, Janbandhu V,
Wystub-Lis K, et al. Single-cell expression profiling reveals dy-
namic flux of cardiac stromal, vascular and immune cells in health
and injury. Elife. 2019;8:1–39. This single-cell RNA-seq time
course study reveals novel, functionally distinct fibroblast sub-
populations in the murine heart and explores their dynamic
changes after injury.
70. Kanisicak O, Khalil H, Ivey MJ, Karch J, Maliken BD, Correll RN,
et al. Genetic lineage tracing defines myofibroblast origin and func-
tion in the injured heart. Nat Commun. 2016;7:12260.
71. Fu X, Khalil H, Kanisicak O, Boyer JG, Vagnozzi RJ, Maliken BD,
et al. Specialized fibroblast differentiated states underlie scar for-
mation in the infarcted mouse heart. J Clin Invest. 2018;128:2127–
43.
72. Croft AP, Campos J, Jansen K, Turner JD, Marshall J, Attar M,
et al. Distinct fibroblast subsets drive inflammation and damage in
arthritis. Nature 2019;570:246–51.
73. Schneider RK, Mullally A, Dugourd A, Peisker F, Hoogenboezem
R, Van Strien PMH, et al. Gli1+ mesenchymal stromal cells are a
key driver of bone marrow fibrosis and an important cellular ther-
apeutic target. Cell Stem Cell. 2017;20:785–800.e8.
74. Walmsley GG, Rinkevich Y, Hu MS, Montoro DT, Lo DD,
McArdle A, et al. Live fibroblast harvest reveals surface marker
shift in vitro. Tissue Eng Part C Methods. 2015;21:314–21.
75. Korosec A, Frech S, Gesslbauer B, Vierhapper M, Radtke C,
Petzelbauer P, et al. Lineage identity and location within the dermis
determine the function of papillary and reticular fibroblasts in hu-
man skin. J Invest Dermatol. 2019;139(2):342–51.
76. Ståhl PL, Salmén F, Vickovic S, Lundmark A, Navarro JF,
Magnusson J, et al. Visualization and analysis of gene expression
in tissue sections by spatial transcriptomics. Science. 2016;353:78–
82.
77. Vickovic S, Eraslan G, Salmén F, Klughammer J, Stenbeck L,
Schapiro D, et al. High-definition spatial transcriptomics for in situ
tissue profiling. Nat Methods. 2019;16:987–90.
Publisher’s Note Springer Nature remains neutral with regard to jurisdic-
tional claims in published maps and institutional affiliations.
33    Page 10 of 10 Curr Rheumatol Rep (2020) 22: 33
